QR-kod

HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ lamivudine /dolutegravir (TLD) roll-out in Mozambique

Abstract Background The World Health Organization (WHO) recommends that HIV treatment scale-up is accompanied by a robust assessment of drug resistance emergence and transmission. The WHO HIV Drug Resistance (HIVDR) monitoring and surveillance strategy includes HIVDR testing in adults both initiatin...

Full beskrivning

Sparad:
Huvudupphov: Nália Ismael, Hernane Gemusse, Isabel Mahumane, Osvaldo Laurindo, Cacildo Magul, Cheryl Baxter, Eduan Wilkinson, L. Marije Hofstra, Nick Wagar, Dulce Bila, Nédio Mabunda, Juliana da Silva, Túlio de Oliveira, Elliot Raizes, Wolfgang Preiser, Pedro Manuel, Artur Ramos, Adolfo Vúbil
Materialtyp: Artigo
Språk:Inglês
Utgiven: BMC 2024-07-01
Serie:BMC Infectious Diseases
Ämnen:
HIV
Drug resistance
Acquired and pre-treatment
Länkar:https://doi.org/10.1186/s12879-024-09579-4
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk